Merck (MRK) FCF Margin (2009 - 2026)

Merck (MRK) has reported FCF Margin for 18 consecutive years, with 26.96% the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Margin rose 1096.0% year-over-year to 26.96% in Q2 2026; TTM through Jun 2026 was 24.13%, a 99.0% increase from a year earlier, with the FY2025 full-year figure at 19.01%, down 919.0% from the prior year.
• FCF Margin was 26.96% for Q2 2026 at Merck, up from 17.97% in the prior quarter.
• Over five years, FCF Margin peaked at 51.08% in Q3 2024 and troughed at 5.08% in Q4 2023.
• A 5-year average of 21.54% and a median of 19.98% in 2022 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin surged 2227 bps in 2022 and plunged 2880 bps in 2023, its largest moves.
• Over 5 years, FCF Margin stood at 23.72% in 2022, then slumped by 121 bps to 5.08% in 2023, then soared by 417 bps to 16.08% in 2024, then slumped by 31 bps to 11.12% in 2025, then surged by 142 bps to 26.96% in 2026.
• The last three FCF Margin figures came in at 26.96% (Q2 2026), 17.97% (Q1 2026), and 11.12% (Q4 2025), per Business Quant data.